Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial

JAMA Oncol. 2025 Feb 27;11(4):426-429. doi: 10.1001/jamaoncol.2024.7051. Online ahead of print.
No abstract available

Plain language summary

This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within the gene body and/or enhancer region.